Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells.

Autor: Ngu, Loveline N.1,2, Nji, Nadesh N.3, Ambada, Georgia3,4, Ngoh, Apeh A.2,5, Njambe Priso, Ghislain D.2,4, Tchadji, Jules C.2,4, Lissom, Abel2,4, Magagoum, Suzanne H.2,4, Sake, Carol N.2,6, Tchouangueu, Thibau F.2,7, Chukwuma, George O.2,8, Okoli, Arinze S.9, Sagnia, Bertrand3, Chukwuanukwu, Rebecca2,8, Tebit, Denis M.10, Esimone, Charles O.11, Waffo, Alain B.12, Park, Chae G.13,14, Überla, Klaus15, Nchinda, Godwin W.2,14 nsehleseh@gmail.com
Zdroj: Immunity, Inflammation & Disease. Mar2018, Vol. 6 Issue 1, p163-175. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje